Riskpilot← Back to searchSign inGet full accessEN Täfteå Läkarkonsult AB
ABIn liquidationOrg 5569302424Economic activity was not specified by tax authority · NACE 0000Est. 20130 employees
Revenue 2021
SEK 0
EBITDA margin
—
-11% vs 2020
Equity ratio
67.5%
Financial strength
Net profit 2021
SEK 82K
-54% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -30K | -11% |
| Net profit | SEK 82K | -54% |
| Total assets | SEK 203K | -51% |
| Equity | SEK 137K | -41% |
| Employees | 0 | — |
Legal name
EN Täfteå Läkarkonsult AB
Org number
5569302424
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
26 april 2013
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Aktiebolaget ska bedriva medicinska konsultationer, utbildning och undervisning inom det medicinska området. Fastighetsförvaltning, värdepappershandel samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 401 | 15 | 7 | 9 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 312 | −41 | −25 | −27 | −30 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 312 | −41 | −25 | −27 | −30 |
| Net financials | — | — | — | — | — |
| Profit before tax | 232 | 4 | 20 | 233 | 105 |
| Tax | −53 | −3 | −6 | −53 | −23 |
| Net profit | 179 | 1 | 14 | 180 | 82 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 1 042 | 829 | 628 | 418 | 203 |
| Equity | 552 | 384 | 228 | 231 | 137 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 5 | 5 | 52 | 65 |
| Total debt | 5 | 5 | 5 | 52 | 65 |
EBITDA margin
-3000000.0%
This company
15.8%
Market median
-18987442% vs market
20172021
Equity ratio
67.5%
This company
38.2%
Market median
+77% vs market
20172021
Return on equity
59.9%
This company
18.4%
Market median
+226% vs market
20172021
Net profit margin
8200000.0%
This company
8.1%
Market median
+101234468% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
MV External Signatory | External Signatory | 2022 – 2022 |
AB External Signatory | External Signatory | 2022 – 2022 |
AE Liquidator | Liquidator | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EN Täfteå Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mona Veronica Vesterberg | External Signatory | 0 companies |
| Anna Birgitta Emanuelsson | External Signatory | 0 companies |
| Anna Elisabeth Adolfsson | Liquidator | 0 companies |
| Erika Rose-Mari Nilsson | Board of Directors | 0 companies |
| Dan Johnny Nilsson | Deputy Board Member | 0 companies |